Stromal vascular fraction cells for the treatment of knee osteoarthritis: a planned clinical trial.

Trial Profile

Stromal vascular fraction cells for the treatment of knee osteoarthritis: a planned clinical trial.

Planning
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2014

At a glance

  • Drugs Stromal vascular fraction (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Sponsors IntelliCell BioSciences
  • Most Recent Events

    • 01 Aug 2014 IntelliCell BioSciences has filed its pre-IND with the FDA for this trial, according to a media release.
    • 12 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top